2019 Pediatric Psychopharmacology Update Institute Notebook
AACAP's 2019 Pediatric Psychopharmacology Update Institute: Early Treatment Intervention: When, What, and For How Long? links the latest findings on the treatment of ADHD, substance abuse, depressive disorders, irritability, suicidal/self-injurious behaviors, psychosis and schizophrenia, anxiety, and high-risk mood and psychotic disorders. Eight top child and adolescent psychiatric researchers detail their approaches to treatment of psychiatric disorders from preschool through transitional age youth with the latest psychiatric medications, discussing medication selection, effectiveness, and expected adverse events. They review the latest data that address balancing benefits and risks across this age range using first-line psychotropic medications in the treatment of youth. In addition to the known, FDA-approved treatments, the speakers describe other relevant treatments that work in conjunction with psychotropic medication.